155 related articles for article (PubMed ID: 37269489)
1. Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers.
Li Y; Li Y; Li L; Xue W; Xin K; Wang T; Shi A
Clin Drug Investig; 2023 Jun; 43(6):413-420. PubMed ID: 37269489
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers.
Peterschmitt MJ; Crawford NPS; Gaemers SJM; Ji AJ; Sharma J; Pham TT
Clin Pharmacol Drug Dev; 2021 Jan; 10(1):86-98. PubMed ID: 32851809
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral AL01211 in Healthy Chinese Volunteers.
Dong L; Xiang J; Babcock M; Cheng Y; Wang Y; Shen Y; Li L; Tan L; Garovoy M; Hu W; Zheng J
Clin Drug Investig; 2024 Jun; 44(6):387-398. PubMed ID: 38698285
[TBL] [Abstract][Full Text] [Related]
4. Tolerability and pharmacokinetics of ranolazine following single and multiple sustained-release doses in Chinese healthy adult volunteers: a randomized, open-label, Latin square design, phase I study.
Tan QY; Li HD; Zhu RH; Zhang QZ; Zhang J; Peng WX
Am J Cardiovasc Drugs; 2013 Feb; 13(1):17-25. PubMed ID: 23355361
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic study of single- and multiple-dosing with metolazone tablets in healthy Chinese population.
Li X; Wang R; Liu Y; Liu Y; Zheng H; Feng Y; Zhao N; Geng H; Zhang W; Wen A
BMC Pharmacol Toxicol; 2017 Nov; 18(1):73. PubMed ID: 29145890
[TBL] [Abstract][Full Text] [Related]
6. Safety and clinical pharmacokinetics of nemonoxacin, a novel non-fluorinated quinolone, in healthy Chinese volunteers following single and multiple oral doses.
Guo B; Wu X; Zhang Y; Shi Y; Yu J; Cao G; Zhang J
Clin Drug Investig; 2012 Jul; 32(7):475-86. PubMed ID: 22650326
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and tolerability of intravenous ibuprofen injection in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study
.
Zhou H; Xu W; Wu G; Wu L; Shentu J; Pan Z; Hu S; Liu Y
Int J Clin Pharmacol Ther; 2016 Nov; 54(11):904-913. PubMed ID: 27569737
[TBL] [Abstract][Full Text] [Related]
8. Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson's Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial.
Peterschmitt MJ; Saiki H; Hatano T; Gasser T; Isaacson SH; Gaemers SJM; Minini P; Saubadu S; Sharma J; Walbillic S; Alcalay RN; Cutter G; Hattori N; Höglinger GU; Marek K; Schapira AHV; Scherzer CR; Simuni T; Giladi N; Sardi SP; Fischer TZ;
J Parkinsons Dis; 2022; 12(2):557-570. PubMed ID: 34897099
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of orally administered single- and multiple-dose olopatadine in healthy Chinese subjects: an open-label study.
Chu NN; Chen WL; Xu HR; Li XN
Clin Drug Investig; 2009; 29(7):451-457. PubMed ID: 19499962
[TBL] [Abstract][Full Text] [Related]
10. Non-Compartmental Pharmacokinetics and Safety of Single-Dose Eldecalcitol (ED-71) in Healthy Chinese Adult Males.
Zhao Q; Liu H; Jiang J; Wu Y; Zhong W; Li L; Miya K; Abe M; Hu P
Clin Drug Investig; 2018 Oct; 38(10):901-908. PubMed ID: 30117129
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and Tolerability of Rufinamide Following Single and Multiple Oral Doses and Effect of Food on Pharmacokinetics in Healthy Chinese Subjects.
Xu M; Ni Y; Zhou Y; He X; Li H; Chen H; Li W
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):541-8. PubMed ID: 26294172
[TBL] [Abstract][Full Text] [Related]
12. Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses.
Wu G; Zheng Y; Zhou H; Hu X; Liu J; Zhai Y; Zhu M; Wu L; Shentu J
Drug Des Devel Ther; 2015; 9():5687-95. PubMed ID: 26527863
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic Properties and Tolerability of Cycloserine Following Oral Administration in Healthy Chinese Volunteers: A Randomized, Open-Label, Single- and Multiple-Dose 3-Way Crossover Study.
Zhou H; Wu G; Hu X; Zhu M; Zhai Y; Liu J; Shentu J; Wu L
Clin Ther; 2015 Jun; 37(6):1292-300. PubMed ID: 25869627
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic characteristics of golidocitinib, a highly selective JAK1 inhibitor, in healthy adult participants.
Chen K; Guan X; Yang Z; Zhou Y; Liu Z; Deng X; Liu D; Hu P; Chen R
Front Immunol; 2023; 14():1127935. PubMed ID: 37077916
[TBL] [Abstract][Full Text] [Related]
15. Phase I, First-in-Human, Single and Multiple Ascending Dose- and Food-Effect Studies to Assess the Safety, Tolerability and Pharmacokinetics of a Novel Anti-hepatitis B Virus Drug, Bentysrepinine (Y101), in Healthy Chinese Subjects.
Liu X; Xue L; Zhang H; Xu Q; Zhang S; Ma S; Ding X; Liu L; Dong J; Qian L; Xia W; Jiang K; Huang C; Miao L
Clin Drug Investig; 2020 Jun; 40(6):555-566. PubMed ID: 32277364
[TBL] [Abstract][Full Text] [Related]
16. Safety, Tolerability, Pharmacokinetics, and Immunogenicity of the Anti-IFNAR1 Monoclonal Antibody QX006N: A First-in-Human Single Ascending Dose Study in Healthy Chinese Volunteers.
Li X; Li B; Wang M; Fang M; Lou J; Liu J; Chen H; Ding Y
BioDrugs; 2024 Mar; 38(2):313-321. PubMed ID: 38148466
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and tolerability of single and multiple doses of ticagrelor in healthy Chinese subjects: an open-label, sequential, two-cohort, single-centre study.
Li H; Butler K; Yang L; Yang Z; Teng R
Clin Drug Investig; 2012 Feb; 32(2):87-97. PubMed ID: 22168538
[TBL] [Abstract][Full Text] [Related]
18. Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial.
Schiffmann R; Cox TM; Dedieu JF; Gaemers SJM; Hennermann JB; Ida H; Mengel E; Minini P; Mistry P; Musholt PB; Scott D; Sharma J; Peterschmitt MJ
Brain; 2023 Feb; 146(2):461-474. PubMed ID: 36256599
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and safety evaluation in healthy Chinese volunteers of alkaloids from leaf of Alstonia scholaris: A multiple doses phase I clinical trial.
Li R; Zi MJ; Gou ZP; Zhao YL; Zhang WT; Lu F; Cao WY; Zhao YP; Li QN; Zhao Y; Wang SG; Gao HY; Sun MY; Luo XD; Xiong ZL; Gao R
Phytomedicine; 2019 Aug; 61():152828. PubMed ID: 31055046
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, safety and tolerability of Bencycloquidium bromide, a novel selective muscarinic M1/M3 receptor antagonist, after single and multiple intranasal doses in healthy chinese subjects: an open-label, single-center, first-in-human study.
Sun L; Ding L; Wang Y; Zhou W; Yan Z; Sun W; Zhang H; Ou N; Chen X
Drugs R D; 2012 Mar; 12(1):17-28. PubMed ID: 22339483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
